Inspire Medical Systems, Inc.·4

May 4, 6:24 PM ET

Tansey Casey M 4

Research Summary

AI-generated summary

Updated

Inspire Medical (INSP) Director Casey M. Tansey Receives Award

What Happened

  • Casey M. Tansey, a director of Inspire Medical Systems, was granted 3,562 Restricted Stock Units (RSUs) on 2026-04-30. The Form 4 reports an acquisition price of $0 (award), so no cash was paid; the filing lists the transaction value as $0. RSUs represent a contingent right to receive one share per RSU once they vest.

Key Details

  • Transaction date and price: 2026-04-30; Grant/Award (code A); reported acquisition price $0.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Vesting / footnote: F1 — Each RSU converts to one share if and when vested; vesting is tied to service (notably a first‑anniversary/service-based vesting condition per the footnote).
  • Other footnotes: F2 and F3 note securities held by The Kimberly Tansey Irrevocable Trust and The Kylie Tansey Irrevocable Trust (these refer to holdings disclosed in the filing).
  • Filing timing: Form filed 2026-05-04 for an April 30 transaction. Form 4s are normally due within two business days of the transaction; this filing date falls outside that window and may be late (check the official filing for a timeliness code).

Context

  • RSU awards are a form of equity compensation, not an open‑market purchase or sale. They typically reflect compensation/retention rather than immediate insider buying or selling sentiment. The RSUs will only result in actual shares if and when the vesting conditions are met.